Dexmedetomidine for reducing succinylcholine-induced myalgia in patients undergoing electroconvulsive therapy: A randomised controlled trial.

Bhavna Sriramka Sasmita Panigrahy Mathan Kumar Ramasubbu Suvendu N Mishra

Published in: Indian journal of anaesthesia (2024)

A low dose of dexmedetomidine (0.25 µg/kg) effectively reduces myalgia and fasciculations due to succinylcholine in patients undergoing electroconvulsive therapy.

Keyphrases

patients undergoing
low dose
cardiac surgery
high glucose
diabetic rats
high dose
acute kidney injury
drug induced
endothelial cells